Benzinga | Nov 1, 2021 04:53AM EDT

Raymond James Maintains Outperform on DexCom, Raises Price Target to $618

Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $515 to $618.